Cancers broncho-pulmonaires secondaires : Cancers broncho-pulmonaires = Secundary bronchopulmonary cancers : Bronchopulmonary carcinomaETIENNE-MASTROÏANNI, Bénédicte; FREYER, Gilles; CORDIER, Jean-Francois et al.La Revue du praticien (Paris). 2003, Vol 53, Num 7, pp 756-759, issn 0035-2640, 4 p.Article

Pharmacodynamic Models for Discrete DataPAULE, Ines; GIRARD, Pascal; FREYER, Gilles et al.Clinical pharmacokinetics. 2012, Vol 51, Num 12, pp 767-786, issn 0312-5963, 20 p.Article

Traitement des cancers: Chirurgie, radiothérapie, chimiothérapie, hormonothérapie. La décision thérapeutique multidisciplinaire et l'information du malade = Treatment of cancer: surgery, radiotherapy, chemotherapy, hormonal therapy. Multidisciplinary therapeutic decision making and informing the patientCLIPPE, Christine; TRILLET-LENOIR, Véronique; FREYER, Gilles et al.La Revue du praticien (Paris). 2003, Vol 53, Num 2, pp 187-198, issn 0035-2640, 12 p.Article

Optimisation de la posologie et des modalités d'administration des agents cytotoxiques à l'aide d'un modèle mathématique = Dosage regimen optimization in cancer chemotherapy using a mathematical modelBARBOLOSI, Dominique; FREYER, Gilles; CICCOLINI, Joseph et al.Bulletin du cancer. 2003, Vol 90, Num 2, pp 167-175, issn 0007-4551, 9 p.Article

Le maniement des médicaments anticancéreux chez les malades âgés = The handling of anti-cancer drugs in elderly patientsGAUJARD, Sylvain; ALBRAND, Gilles; BONNEFOY, Marc et al.La Presse médicale (1983). 2005, Vol 34, Num 9, pp 673-680, issn 0755-4982, 8 p.Article

Tumeur à cellules de la granulosa : revue de la littérature = Granulosa cell tumour : review of the literatureBOMPAS, Emmanuelle; FREYER, Gilles; VITREY, Danielle et al.Bulletin du cancer. 2000, Vol 87, Num 10, pp 709-714, issn 0007-4551Article

Pharmacology of cytotoxic agents: a helpful tool for building dose adjustment guidelines in the elderlyTRANCHAND, Brigitte; LAPORTE, Silvy; GLEHEN, Olivier et al.Critical reviews in oncology/hematology. 2003, Vol 48, Num 2, pp 199-214, issn 1040-8428, 16 p.Conference Paper

Les enjeux de l'observance pour les nouvelles chimiothérapies par voie orale : intérêt du modèle pharmacocinétique-pharmacodynamique : Optimisation des traitements anticancéreux de l'enfant et de l'adulte = Issues of the study of patient compliance to treatment with oral anticancer chemotherapy : Advantages of pharmacokinetics-pharmacodynamics modelisationHENIN, Emilie; YOU, Benoit; TRANCHAND, Brigitte et al.Thérapie (Paris). 2007, Vol 62, Num 2, pp 77-85, issn 0040-5957, 9 p.Conference Paper

Links Between Cyclosporin Exposure in Tissues and Graft-Versus-Host Disease in Pediatric Bone Marrow Transplantation: Analysis by a PBPK ModelGERARD, Cécile; BLEYZAC, Nathalie; GIRARD, Pascal et al.Pharmaceutical research. 2011, Vol 28, Num 3, pp 531-539, issn 0724-8741, 9 p.Article

Biology of Cancer and Aging: A Complex Association With Cellular SenescenceFALANDRY, Claire; BONNEFOY, Marc; FREYER, Gilles et al.Journal of clinical oncology. 2014, Vol 32, Num 24, pp 2604-2610, issn 0732-183X, 7 p.Article

Predicting everolimus treatment efficacy in patients with advanced endometrial carcinoma: a GINECO group studyTREDAN, Olivier; TREILLEUX, Isabelle; LAVAU-DENES, Sandrine et al.Targeted oncology. 2013, Vol 8, Num 4, pp 243-251, issn 1776-2596, 9 p.Article

Adjuvant docetaxel/cyclophosphamide in breast cancer patients over the age of 70: Results of an observational studyFREYER, Gilles; CAMPONE, Mario; PERON, Julien et al.Critical reviews in oncology/hematology. 2011, Vol 80, Num 3, pp 466-473, issn 1040-8428, 8 p.Article

Pharmacologie des agents anticancéreux chez le sujet âgé : une aide à l'adaptation des doses = Pharmacology of anticancer drugs in the elderly : tools for dose-adjustmentTRANCHAND, Brigitte; FALANDRY, Claire; YOU, Benoit et al.Bulletin du cancer. 2008, Vol 95, Num AVRIL, issn 0007-4551, F21-F27, NSArticle

Addition of oxaliplatin to continuous fluorouracil, L-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 Phase I trialFREYER, Gilles; BOSSARD, Nadine; ROMESTAING, Pascale et al.Journal of clinical oncology. 2001, Vol 19, Num 9, pp 2433-2438, issn 0732-183XArticle

Dose adaptation of capecitabine based on individual prediction of limiting toxicity grade: evaluation by clinical trial simulationPAULE, Ines; TOD, Michel; HENIN, Emilie et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 2, pp 447-455, issn 0344-5704, 9 p.Article

Le cancer du sein de la femme âgée (hors situation métastatique)BRAIN, Etienne; CAROLA, Elisabeth; FALANDRY, Claire et al.Oncologie (Paris). 2011, Vol 13, Num 10-11, pp 755-757, issn 1292-3818, 3 p.Conference Paper

Influence of Dosing Schedule on Organ Exposure to Cyclosporin in Pediatric Hematopoietic Stem Cell Transplantation: Analysis with a PBPK ModelGERARD, Cécile; BLEYZAC, Nathalie; GIRARD, Pascal et al.Pharmaceutical research. 2010, Vol 27, Num 12, pp 2602-2613, issn 0724-8741, 12 p.Article

Lhermitte sign and urinary retention: Atypical presentation of oxaliplatin neurotoxicity in four patientsTAIEB, Sarah; TRILLET-LENOIR, Véronique; RAMBAUD, Loïc et al.Cancer. 2002, Vol 94, Num 9, pp 2434-2440, issn 0008-543XArticle

Traitement du cancer de la prostate métastatique chez le sujet âgé = Metastatic prostate cancer treatment in the elderlyFALANDRY, Claire; BONNEFOY, Marc; YOU, Benoit et al.Bulletin du cancer. 2007, Vol 94, Num 6, issn 0007-4551, F89-F96, SUPArticle

Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor―Positive, Human Epidermal Growth Factor Receptor 2―Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO StudyBACHELOT, Thomas; BOURGIER, Céline; LEGOUFFE, Eric et al.Journal of clinical oncology. 2012, Vol 30, Num 22, pp 2718-2724, issn 0732-183X, 7 p.Article

Pharmacogenetic Tailoring of Irinotecan-based First-line Chemotherapy in Metastatic Colorectal Cancer: Results of a Pilot StudyFREYER, Gilles; DURET, Aude; MILANO, Gerard et al.Anticancer research. 2011, Vol 31, Num 1, pp 359-366, issn 0250-7005, 8 p.Article

Le cancer du sein sans envahissement ganglionnaire. Au-delà des consensus internationaux: une approche pragmatique = Node negative breast cancer. Beyond international consensus: a pragmatic approachPENAULT-LLORCA, Frédérique; COEFFIC, David; PETIT, Thierry et al.Bulletin du cancer. 2011, Vol 98, Num 7, pp 807-825, issn 0007-4551, 19 p.Article

Tumeurs malignes primitives du péritoine : étude d'une série de huit cas et revue de la littérature = Primary peritoneal tumors : report on a series of eight cases and review of the literatureCLIPPE, Christine; FREYER, Gilles; BIZOLLON, Marie-Hélène et al.Bulletin du cancer. 2002, Vol 89, Num 4, pp 430-436, issn 0007-4551Article

The prognostic value of etoposide area under the curve (AUC) at first chemotherapy cycle in small cell lung cancer patients : a multicenter study of the groupe Lyon-Saint-Etienne d'Oncologie Thoracique (GLOT)FREYER, Gilles; LIGNEAU, Blandine; TRILLET-LENOIR, Véronique et al.Lung cancer. 2001, Vol 31, Num 2-3, pp 247-256, issn 0169-5002Article

Quantitative evaluation of the combination between cytotoxic drug and efflux transporter inhibitors based on a tumour growth inhibition modelSOSTELLY, Alexandre; PAYEN, Léa; GUITTON, Jérôme et al.Fundamental & clinical pharmacology. 2014, Vol 28, Num 2, pp 161-169, issn 0767-3981, 9 p.Article